Leucine Rich Bio, now unveils its #HappyGutMission campaign an initiative designed to educate people on the critical role of gut health. This campaign has brought gut health to the forefront, offering ...
US FDA advisory panel votes in favour of IceCure's ProSense cryoablation benefit-risk profile in early-stage low risk breast cancer: Caesarea, Israel Monday, November 11, 2024, 15 ...
Johnson & Johnson announced the submission of regulatory applications to the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) seeking approval of a new indication for Darzalex ...
Quantiphi and DDReg partner to transform regulatory reporting in life sciences through AI: Our Bureau, Bengaluru Monday, November 11, 2024, 13:45 Hrs [IST] Quantiphi, a global AI- ...
EMA's Committee for Veterinary Medicinal Products (CVMP) has issued the first certificate for a vaccine platform technology master file (vPTMF) which will support and accelerate the development and ...
US FDA clears SystImmune’s IND application for BL-M17D1 in advanced solid tumours: Redmond, Washington Monday, November 11, 2024, 14:00 Hrs [IST] SystImmune, Inc (SystImmune), a ...
The recent amendments brought by the Union Ministry of Ayush to the Drugs and Cosmetics Rules, 1945 are significant, as they introduce new regulatory requirements for the manufacturing and sale of ...
Centre notifies rules for recruitment of medical device officers in CDSCO: Gireesh Babu, New Delhi Monday, November 11, 2024, 08:00 Hrs [IST] In an effort to strengthen the regula ...
Nammi Therapeutics begins patient dosing in phase 1 study of QXL138AM for advanced solid tumours and multiple myeloma: Los Angeles Monday, November 11, 2024, 13:00 Hrs [IST] Nammi ...
Health Vectors unveils Smart Health Report to spur future of personal health analytics: Our Bureau, Bengaluru Monday, November 11, 2024, 12:30 Hrs [IST] Health Vectors (HV), a hea ...
RPG Life Sciences appoints Ashok Nair as managing director (designate) following superannuation of Yugal Sikri: Our Bureau, Bengaluru Monday, November 11, 2024, 12:15 Hrs [IST] RP ...
Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older: Cambridge, Massachusetts Monday, November 11, 2024, 12:00 Hrs [IST] Moderna, Inc., a le ...